高级检索
当前位置: 首页 > 详情页

Association between Subclinical Hypothyroidism and Proliferative Diabetic Retinopathy in Type 2 Diabetic Patients: A Case-Control Study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Dept Endocrinol, Beijing Tongren Hosp, Beijing 100730, Peoples R China
出处:
ISSN:

关键词: subclinical hypothyroidism proliferative diabetic retinopathy type 2 diabetes thyrotropin diabetic complication

摘要:
Subclinical hypothyroidism (SCH) is defined as an asymptomatic state characterized by normal serum levels of free thyroxine and elevated serum concentrations of thyrotropin (>4.0 mu U/ml). The association between SCH and type 2 diabetes has been well established. Proliferative diabetic retinopathy (PDR) that is characterized by neovascularization is a leading cause of visual loss in adults worldwide. However, whether SCH is related to PDR has not been studied. This study thus aimed to evaluate the relationship between SCH and PDR in type 2 diabetes. A total of 371 type 2 diabetic subjects were enrolled: 187 subjects with PDR and 184 subjects without diabetic retinopathy (with HbA1c above 6.5% and at least 10 years of diabetes duration). Subjects with PDR had higher blood pressure, higher serum levels of total cholesterol, low-density lipoprotein cholesterol and thyrotropin, and higher urinary albumin excretion rate. Of the 371 diabetics, 83 subjects (22.4%) were diagnosed as SCH (male 12.1% and female 29.9%). The prevalence of SCH in the PDR group (51/187, 27.3%) was higher than that in the subjects without diabetic retinopathy (32/184, 17.4%). Logistic regression analysis showed that after adjusting for compounding variables, SCH was independently related with PDR (p = 0.032, adjusted OR = 2.485). These results indicate that type 2 diabetic patients with PDR are at an increased risk of SCH. A routine screening for thyroid function may thus be considered advisable in PDR subjects. This may be helpful in investigating new strategies preventing or treating PDR in clinical practice.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2009]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科 4 区 医学:研究与实验
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科 4 区 医学:研究与实验
JCR分区:
出版当年[2008]版:
Q3 MEDICINE, GENERAL & INTERNAL Q3 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2024]版:
Q2 MEDICINE, GENERAL & INTERNAL Q3 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2024版] 最新五年平均 出版当年[2008版] 出版当年五年平均 出版前一年[2007版] 出版后一年[2009版]

第一作者:
第一作者机构: [1]Capital Med Univ, Dept Endocrinol, Beijing Tongren Hosp, Beijing 100730, Peoples R China
通讯作者:
通讯机构: [1]Capital Med Univ, Dept Endocrinol, Beijing Tongren Hosp, Beijing 100730, Peoples R China [*1]Capital Med Univ, Dept Endocrinol, Beijing Tongren Hosp, 1 Dongjiaomin Xiang, Beijing 100730, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:28499 今日访问量:0 总访问量:1584 更新日期:2025-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)